Author

Sifen Wang

Observed name: Wang, Si-Fen

Institutions: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China

Observed institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Esophageal Cancer Research Institute

OpenAlex ID: A5020764821

POP1 Facilitates Proliferation in Triple-Negative Breast Cancer via m6A-Dependent Degradation of CDKN1A mRNA

2024 · Chao Zhang, Sifen Wang, et al. · Research · 62

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy

2023 · Xingyuan Cheng, Baoqing Chen, et al. · The Oncologist · 19

TBL2 Promotes Tumorigenesis via PRMT5/WDR77‐Mediated AKT Activation in Breast Cancer

2024 · Xiuqing Lu, Chao Zhang, et al. · Advanced Science · 10

Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery

2022 · Zhaohui Liang, Kongjia Luo, et al. · Annals of Surgical Oncology · 10

Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer

2023 · Xiuqing Lu, Qi Yuan, et al. · Frontiers in Oncology · 8

Induction chemotherapy plus chemoradiotherapy in esophageal cancer: long-term results and exploratory analyses of a randomized controlled trial

2024 · Shiliang Liu, Baoqing Chen, et al. · The Oncologist · 7

Risk factors and prognosis for esophageal fistula in patients with esophageal squamous cell carcinoma during radiotherapy

2022 · Sifen Wang, Chao Zhang, et al. · Esophagus · 6

Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials

2026 · BaoQing Chen, Junying Chen, et al. · Journal for ImmunoTherapy of Cancer · 1

The Intratumoral Microbiota in Breast Cancer: Roles in Progression, Immunity, and Therapy

2026 · Zhihao Wei, Jijie Cai, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

ASO Visual Abstract: Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy and Surgery

2022 · Zhaohui Liang, Kongjia Luo, et al. · Annals of Surgical Oncology

Works count: 14

Citation count: 123

H-index: 6

I10-index: 4